Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

McGill University

$120,000.00

The role of the TOM and TIM complexes in stabilizing PINK1 on damaged mitochondria

EF 2025-26

Résumé
Parkinson's disease (PD) is the most common movement disorder caused by the death of specific brain cells, leading to impairments, such as tremors. By 2031, around 163,000 Canadians will be diagnosed with PD, however current treatments do not slow disease progression and have severe side effects. We are in dire need of new therapeutic targets. To do so, we must better understand key players causing PD. Early-onset PD is caused by the protein PINK1 not working properly in our brain. Similar to a fire alarm, PINK1 is able to signal to our bodies that damage in our brain cells needs to be removed. It detects a special type of damage, known as mitochondrial damage. Mitochondria are inside our cells, responsible for providing energy. Unfortunately, mitochondria can become damaged and this damaged needs to be removed to keep us healthy. PINK1 will signal to our bodies that this damage needs to be cleared. However, in PD, PINK1 stops working leading to an accumulation of damage in our brain cells and brain cell death. To find therapeutics to fix PINK1, my work focuses on investigating how PINK1 works in the brains of healthy individuals. Once we understand how PINK1 works, we can then create new drugs. For PINK1 to signal to our body that damage needs to be removed, it needs to interact with a part of the damaged mitochondria known as TOM (translocase of the outer membrane) and TIM (translocase of the inner membrane). However, the way that PINK1 interacts with TOM and TIM is still unclear. Our objective is to better understand these interactions to give us more information about how PINK1 works. We will use biochemical approaches to examine key connections between PINK1, TOM and TIM. This PINK1-TOM-TIM interaction is the crucial initiator of a damage repair pathway implicated in PD. It serves as a new therapeutic target, with the goal of reducing patient suffering and the economic burden associated with long-term care of PD.
Programme
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
560217
Name
Romanelli Sabrina
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
The role of the TOM and TIM complexes in stabilizing PINK1 on damaged mitochondria
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Damage Sensing; Mitochondria; Parkin; Parkinson'S Disease; Pink1; Pink1-Tom-Tim Complex; Tim-Complex; Tim50; Tom-Complex; Tom7
Abstract
Parkinson's disease (PD) is the most common movement disorder caused by the death of specific brain cells, leading to impairments, such as tremors. By 2031, around 163,000 Canadians will be diagnosed with PD, however current treatments do not slow disease progression and have severe side effects. We are in dire need of new therapeutic targets. To do so, we must better understand key players causing PD. Early-onset PD is caused by the protein PINK1 not working properly in our brain. Similar to a fire alarm, PINK1 is able to signal to our bodies that damage in our brain cells needs to be removed. It detects a special type of damage, known as mitochondrial damage. Mitochondria are inside our cells, responsible for providing energy. Unfortunately, mitochondria can become damaged and this damaged needs to be removed to keep us healthy. PINK1 will signal to our bodies that this damage needs to be cleared. However, in PD, PINK1 stops working leading to an accumulation of damage in our brain cells and brain cell death. To find therapeutics to fix PINK1, my work focuses on investigating how PINK1 works in the brains of healthy individuals. Once we understand how PINK1 works, we can then create new drugs. For PINK1 to signal to our body that damage needs to be removed, it needs to interact with a part of the damaged mitochondria known as TOM (translocase of the outer membrane) and TIM (translocase of the inner membrane). However, the way that PINK1 interacts with TOM and TIM is still unclear. Our objective is to better understand these interactions to give us more information about how PINK1 works. We will use biochemical approaches to examine key connections between PINK1, TOM and TIM. This PINK1-TOM-TIM interaction is the crucial initiator of a damage repair pathway implicated in PD. It serves as a new therapeutic target, with the goal of reducing patient suffering and the economic burden associated with long-term care of PD.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Romanelli, Sabrina
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~